Philip D. Henry
#167,216
Most Influential Person Now
Philip D. Henry's AcademicInfluence.com Rankings
Philip D. Henrymedical Degrees
Medical
#3457
World Rank
#3926
Historical Rank
Cardiology
#369
World Rank
#380
Historical Rank
Philip D. Henryphilosophy Degrees
Philosophy
#9899
World Rank
#13523
Historical Rank
Logic
#6851
World Rank
#8406
Historical Rank
Download Badge
Medical Philosophy
Philip D. Henry's Degrees
- Bachelors Biology University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
- PhD Cardiology Stanford University
Similar Degrees You Can Earn
Why Is Philip D. Henry Influential?
(Suggest an Edit or Addition)Philip D. Henry's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) (1999) (4830)
- Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. (1980) (894)
- Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins (1990) (888)
- Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. (1987) (565)
- Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. (1981) (423)
- An Improved Basis for Enzymatic Estimation of Infarct Size (1975) (406)
- Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. (1999) (403)
- Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. (1977) (313)
- Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism. (1980) (285)
- Effects of Nifedipine on Myocardial Perfusion and Ischemic Injury in Dogs (1978) (251)
- Preservation of Endothelium, Dependent Vascular Relaxation in Cholesterol, Fed Rabbit by Treatment with the Calcium Blocker PN 200110 (1986) (228)
- External Detection and Visualization of Myocardial Ischemia with 11C‐Substrates in Vitro and in Vivo (1976) (182)
- Quantification of serum creatine phosphokinase isoenzyme activity. (1974) (172)
- Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. (1993) (155)
- Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription (2003) (151)
- Rapid separation of plasma creatine kinase isoenzymes by batch adsorption on glass beads. (1975) (142)
- Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. (1988) (129)
- Nifedipine: a myocardial protective agent. (1979) (116)
- Atherosclerosis, calcium, and calcium antagonists. (1985) (111)
- Sensitization of Isolated Canine Coronary Arteries to Calcium Ions after Exposure to Cholesterol (1979) (110)
- Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. (2000) (108)
- Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. (1979) (94)
- Pharmacological preservation of the ischemic heart. (1977) (90)
- Autofluorescence maps of atherosclerotic human arteries--A new technique in medical imaging (1987) (86)
- Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants. Essential role of basic fibroblast growth factor. (1997) (77)
- Lack of protection of ischemic myocardium by verapamil in conscious dogs. (1977) (73)
- Fibroblast growth factor 2: from laboratory evidence to clinical application. (2004) (71)
- XeCl laser ablation of atherosclerotic aorta: Optical properties and energy pathways (1992) (69)
- Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. (1997) (66)
- Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. (1999) (62)
- Endothelium-dependent relaxation in human saphenous vein grafts. Effects of preparation and clinicopathologic correlations. (1990) (58)
- Antiperoxidative Actions of Calcium Antagonists and Atherogenesis (1991) (58)
- Oxidized Low-Density Lipoprotein Downregulates Endothelial Basic Fibroblast Growth Factor Through a Pertussis Toxin-Sensitive G-Protein Pathway: Mediator Role of Platelet-Activating Factor-Like Phospholipids (2001) (57)
- Inotropic and chronotropic effects of vasodilators. (1982) (57)
- Spontaneous Ventricular Tachycardia Treated by Antitachycardia Pacing (1997) (55)
- Calcium Antagonists as Antiatherogenic Agents (1988) (52)
- Improved performance of ischemic canine myocardium in response to nifedipine and diltiazem. (1980) (52)
- Depressed Adenyl Cyclase Activity in the Failing Guinea Pig Heart (1969) (52)
- Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. (1997) (51)
- Atherogenesis, calcium and calcium antagonists. (1990) (50)
- Protection of hypoxic guinea pig hearts with glucose and insulin. (1974) (47)
- Hypoxic contraction of isolated canine coronary artery. Mediation by potassium-dependent exocytosis of norepinephrine. (1980) (45)
- Dissociations between Changes in Myocardial Cyclic Adenosine Monophosphate and Contractility (1975) (43)
- Depressed inotropic state and reduced myocardial oxygen consumption in the human heart. (1973) (43)
- Atherosclerosis as a microvascular disease: impaired angiogenesis mediated by suppressed basic fibroblast growth factor expression. (1997) (40)
- Myocardial preservation with nifedipine: a comparative study at normothermia. (1981) (40)
- Effects of potassium on isolated canine coronary arteries. Modulation of adrenergic responsiveness and release of norepinephrine. (1977) (39)
- XeCl laser-induced fluorescence of atherosclerotic arteries. Spectral similarities between lipid-rich lesions and peroxidized lipoproteins. (1993) (38)
- Altering molecular mechanisms to prevent sudden arrhythmic death (1998) (36)
- Positive staircase effect in the rat heart. (1975) (36)
- Laser‐Induced Autofluorescence of Human Arteries (1988) (35)
- Hyperlipidemic arterial dysfunction. (1990) (34)
- Simultaneously Measured Isometric Tension and ATP Hydrolysis in Glycerinated Fibers from Normal and Hypertrophied Rabbit Heart (1972) (34)
- Inflammatory mechanisms of atheroma formation. Influence of fluid mechanics and lipid-derived inflammatory mediators. (1993) (33)
- Coronary Artery Spasm in Intact Dogs Induced by Potassium and Serotonin (1983) (33)
- Calcium Channel Blockers and Atherosclerosis (1990) (33)
- Laboratory and Initial Clinical Studies of Nifedipine, A Calcium Antagonist for Improved Myocardial Preservation (1981) (31)
- Calcium antagonists as anti-atherosclerotic agents. (1990) (30)
- Tissue interactions and measurement of ablation rates with ultraviolet and visible lasers in canine and human arteries (1987) (29)
- Activation of Phosphorylase by Cyclic AMP without Augmentation of Contractility in the Perfused Guinea Pig Heart (1971) (27)
- Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines (2011) (27)
- Hypercholesterolemia and endothelial dysfunction. (1995) (27)
- XeCl laser ablation of atherosclerotic aorta: Luminescence spectroscopy of ablation products (1993) (27)
- Structural Pathways and Prevention of Heart Failure and Sudden Death (2003) (26)
- Ablation for atrial fibrillation: are cures really achieved? (2004) (24)
- Comparison of results in two implantable defibrillators (1998) (22)
- Altered myocardial lactic dehydrogenase isoenzymes in experimental cardiac hypertrophy. (1970) (21)
- Increased serum creatine phosphokinase activity in experimental pulmonary embolism. (1970) (21)
- Diltiazem and nitrendipine suppress hypoxic contracture in quiescent ventricular myocardium. (1983) (19)
- Nifedipine and acute myocardial infarction. (1981) (16)
- Impaired adaptive vascular growth in hypercholesterolemic rabbit. (1998) (15)
- Autologous pulmonary embolism in the intact, unanesthetized dog. (1970) (15)
- Effects of intracoronary acetylcholine infusion early versus late after heart transplant. (1991) (15)
- Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitro. (1995) (15)
- Chemical laser interactions with human cardiovascular tissue (1988) (13)
- Spontaneous ventricular tachycardia treated by antitachycardia pacing. Cadence Investigators. (1997) (13)
- AnImproved Basis forEnzymatic Estimation ofInfarct Size (1975) (13)
- Demonstration of physiological transit time of sonicated meglumine diatrizoate in a microvascular preparation (1987) (11)
- Stress fibers in endothelial cells overlying atherosclerotic lesions in rabbit aorta. (1989) (11)
- Calcium channel blockers and progression of coronary artery disease. (1990) (11)
- Hyperlipidemic endothelial injury and angiogenesis. (1994) (11)
- Use of nifedipine to decrease ischemic-reperfusion injury in the surgical setting. (1985) (11)
- Angiographic dye relaxes canine coronary artery by a nonosmotic mechanism (1981) (10)
- Impaired endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta (1987) (9)
- Anti-atherosclerotic effects of calcium antagonists: a brief review. (1987) (9)
- Hypercholesterolemia and angiogenesis. (1993) (9)
- An Additional Low Molecular Weight Subunit in Purified Preparations of Myosin from Hypertrophied Myocardium (1973) (9)
- Class I or Class III Agents for Atrial Fibrillation: (2003) (9)
- Impaired cholinergic vasodilation in the cholesterol-fed rabbit in vivo (1987) (8)
- Transfer of lysophosphatidylcholimb from oxidised ldl to endothelial cklls impairs endotheliom dependent arterial relaxation (1990) (8)
- Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. (1978) (7)
- Cyclic-AMP in the Perfused Failing Guinea Pig Heart 1 (1971) (6)
- Comparison of results in two implantable defibrillators. Jewel 7219D Investigators. (1998) (6)
- Intravascular Imaging With Ultrasound (1988) (6)
- Chemical Laser Interactions With Human Cardiovascular Tissues (1988) (6)
- Sudden cardiac death: still more questions than answers. (1997) (5)
- The cholesterol pessimist. (1988) (5)
- Spontaneous coronary artery dissection in a woman on fenfluramine. (2007) (5)
- Protection of ischemic myocardium in conscious dogs with Nifedipine (1976) (5)
- The authors of the paper in question responded as follows (1975) (5)
- Glucagon, myocardial contractility, and cyclic AMP (1973) (4)
- Hypoxic coronary contraction mediated by beta2, adrenergic receptors (1978) (4)
- Suppression of Atherogenesis with a Membrane-Active Agent—Nifedipine (1982) (4)
- Inappropriate Coronary Vasomotion Excessive Constriction and Insufficient Dilation (1989) (4)
- Experimental coronary artery spasm in intact dog: Angiographic characterization, recording of flow, and response to dihydropyridines (1981) (3)
- Effects of low‐density lipoproteins and hypercholesterolemia on endothelium‐dependent vasodilation (1991) (3)
- Endothelium-Dependent Relaxation of Rabbit Aorta (2005) (3)
- Antiatherogenic effects of calcium-channel blockers: Possible mechanisms of action (1990) (3)
- Atherosclerotic tissue analysis by time‐resolved XeCl excimer laser reflectometry (1993) (3)
- Protection of the Globally Ischemic Heart with Calcium-Antagonists: Improved Recovery After Cardiopulmonary Bypass (1980) (3)
- Dyslipoproteinaemia, signal transduction, and angiogenesis. (1993) (3)
- Quantification of creatine phosphokinase (CPK) isozymes in serum (1973) (3)
- Vasoprotection and antihypertensive therapy. (1995) (3)
- Hyperlipidemic arterial disease (1991) (3)
- Overview of Instrumentation (2002) (3)
- Ketanserin — A selective serotonergic blocking agent in vascular smooth muscle (1982) (2)
- Implantable Defibrillator Therapy: A Clinical Guide (2002) (2)
- Clinical pharmacology of calcium antagonists. (1984) (2)
- Coronary Artery Spasm (1984) (2)
- Impaired production of cyclic-AMP in the failing heart☆ (1969) (1)
- Membrane cholesterol and cellular calcium uptake. (1990) (1)
- Late Changes in Saphenous Vein Aorto-Coronary Bypass Grafts: Clinical, Angiographic, Lipid and Pathological Correlations (1990) (1)
- Effects of Calcium Antagonists on Injured Cells (1984) (1)
- Oxidatively modified low-density lipoprotein in mononuclear cells detected by laser-induced fluorescence spectroscopy (1995) (1)
- Effect of preexisting epicardial patch electrodes on defibrillation thresholds of unipolar defibrillators. (1997) (1)
- Myocardial Protection by a Calcium Antagonist (1979) (1)
- Characterization of normal and diseased tissue by argon-ion laser-induced fluorescence (1987) (1)
- Increased oxygen consumption in cholesterol-fed rabbits. (1977) (1)
- Mono aminergic receptor shift in athero sclerotic rabbit aorta (1981) (1)
- Antiperoxidative actions of calcium antagonists and atherogenesis. Discussion (1991) (0)
- A Direct Thermochemical Approach to the Digitoxin / Albumin Interaction (2004) (0)
- Vascular Regulation in Atherosclerosis (1991) (0)
- Inhibiting Fibroblast Growth Factor 2 Transcription Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular (2003) (0)
- Electromagnetic Interference (EMI) (2002) (0)
- Anxiety and Depression (2002) (0)
- Platelet-activating factor-like lipids mediate endothelial cell apoptosis induced by hypercholesterolemic low-density lipoprotein (2003) (0)
- Potassium-dependent exocytosis of norepinephrine from hypoxic canine coronary artery (1978) (0)
- Comment Calcium Channel Blockers and Progression of Coronary Artery Disease (2005) (0)
- Oxidized LDL-induced endothelial cell apoptosis: Role of mediator phospholipids and bFGF (2000) (0)
- May calcium antagonists retard the progression of atherosclerosis in humans (1992) (0)
- Changes in the subunit composition of myosin from hearts undergoing hypertrophy (1974) (0)
- POSTOPERATIVE FOLLOW-UP AND COMPLICATIONS (2002) (0)
- Laser-tissue interactions: cw and pulsed HF/DF chemical laser interactions with cardiovascular tissues (1987) (0)
- Detection of calcium activity in human monocytes by the fura-2 fluorescence method: in vitro differentiation sensitizes cells to dihydropyridine calcium channel modulators (1994) (0)
- Growth factor regulation of microvascular outgrowth from rabbit aortic explants (1994) (0)
- Atrial Fibrillation Should Be Considered a First-Line Therapy — Or Not? (2006) (0)
- Tissue morphologic analysis and ablation rates in the UV and visible for laser angioplasty (2008) (0)
- 1122-171 Atherogenic low-density lipoprotein impairs vascular endothelial cell survival by disrupting the FGF2-PI3K-Akt autoregulatory loop (2004) (0)
- 820-4 Effective reduction of novel atherogenic low-density lipoprotein subfraction by atorvastatin in patients with hypercholesterolemia (2004) (0)
- Calcium Antagonists for the Treatment of Atherosclerosis (1991) (0)
- Calcium Channel Blockers as Agents for the Treatment of Atherosclerosis (1993) (0)
- Laser-induced fluorescence in atherogenesis: assessment of endothelium and macrophages (1995) (0)
- Responsiveness of atherosclerotic rabbit aorta to adrenergic and cholinergic stimulation (1980) (0)
- The contractile apparatus in heart failure (1973) (0)
- Nifedipine: A Pleiotropic Vascular Drug (1991) (0)
- Adjunctive Antiarrhythmic Drug Therapy (2002) (0)
- 1116-29 Role of the lipoxygenase-1 receptor in transducing the apoptotic signals of circulating atherogenic low-density lipoprotein (2004) (0)
- XeCl laser-induced fluorescence detection of peroxidized lipoproteins in lipid-rich atherosclerotic lesions (1993) (0)
- Working Toward an Efficient Electrophysiology Practice (1998) (0)
- MEMBRANE CHOLESTEROL AND CELLULAR CALCIUM UPTAKE. REPLY (1990) (0)
- ETAantagonist BQ123 inhibits endothelin-1-induced vasoconstriction in flow-loaded rabbit carotid, betic rat, and atherosclerotic human coronary arteries (1996) (0)
- Circulation Research provides a medium for bringing together basic research on the cardiovascular sys- tem from various disciplines including biology, biochemistry, biophysics, morphology, pathology, physiology, and pharmacology. The Journal also will accept for publication manuscripts on clinical r (1977) (0)
- Hypercholesterolemia and angiogenesis. Discussion (1993) (0)
- ICD Trial Appendix (2002) (0)
- Positive inotropic effect of α-adrenergic stimulation in intact dog hearts (1979) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Philip D. Henry?
Philip D. Henry is affiliated with the following schools:
